Stockreport

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity

Serina Therapeutics, Inc.  (SER) 
PDF HUNTSVILLE, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the "Company") (NYSE American: SER), a clinical-stage biotechnology company advanc [Read more]